B

BTAI

Bioxcel Therapeutics Inc

4.04

0.63+18.48%
After Hours: 4.200  +0.160  +3.97%19:59 08/08 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

2.27M

1.38M

375.00K

0

0

Net Income

-59.60M

-179.05M

-165.76M

-106.93M

-82.17M

ROE

0.7967

-17.6694

-1.1108

-0.4993

-0.7035

ROA

-1.0639

-1.281

-0.7445

-0.4655

-0.6411

EPS

-23.5105

-98.3505

-94.6674

-64.8731

-60.6328

BVPS

-30.0132

-30.208

43.6422

126.7574

135.4442

Asset Turnover

0.0404

0.0099

0.0017

0

0

Debt-to-Asset

3.4284

1.7667

0.627

0.0742

0.0602

Current Ratio

1.6819

2.6458

6.1666

14.2084

18.3301

Quick Ratio

1.6514

2.5728

6.1062

--

--